Towa Pharmaceutical Co., Ltd. (TWAPF)
25.33
0.00 (0.00%)
USD |
OTCM |
May 29, 16:00
Towa Pharmaceutical EPS Diluted (Quarterly) : -1.532 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | -0.0496 |
| Daiichi Sankyo Co., Ltd. | 0.1472 |
| Eisai Co., Ltd. | -0.0184 |
| Chugai Pharmaceutical Co., Ltd. | 0.2235 |
| Santen Pharmaceutical Co., Ltd. | 0.3043 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -75.41M |
| Revenue (Quarterly) | 443.89M |
| Total Expenses (Quarterly) | 519.30M |
| Enterprise Value | 2.387B |
| Gross Profit Margin (Quarterly) | 34.44% |
| Profit Margin (Quarterly) | -16.99% |
| Earnings Yield | 3.06% |
| Operating Earnings Yield | 12.29% |